Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
A Phase 1, Randomized, Double Blind, Placebo Controlled, Multiple Dose, 2 Way Crossover Study To Evaluate The Safety And Pharmacodynamic Effects Of Pf 06282999 Using An Endotoxin (Lipopolysaccharide) Induced Inflammatory Response Model In Healthy Adult Subjects
Status: Enrolling
Updated:  7/6/2015
1052
mi
from
Durham, NC
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
A Phase 1, Randomized, Double Blind, Placebo Controlled, Multiple Dose, 2 Way Crossover Study To Evaluate The Safety And Pharmacodynamic Effects Of Pf 06282999 Using An Endotoxin (Lipopolysaccharide) Induced Inflammatory Response Model In Healthy Adult Subjects
Status: Enrolling
Updated: 7/6/2015
Duke Clinical Research Unit
1052
mi
from
Durham, NC
Click here to add this to my saved trials
MLN3126 Single Rising Dose Study
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study of Escalating Single Doses of MLN3126 in Healthy Subjects
Status: Enrolling
Updated:  7/7/2015
1283
mi
from
Eatontown, NJ
MLN3126 Single Rising Dose Study
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study of Escalating Single Doses of MLN3126 in Healthy Subjects
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
1283
mi
from
Eatontown, NJ
Click here to add this to my saved trials
DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
A Phase 1, Single-center, Open-label, Two-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Digoxin (Lanoxin®), a Sensitive P-glycoprotein (P-gp) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated:  7/8/2015
340
mi
from
Dallas, TX
DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
A Phase 1, Single-center, Open-label, Two-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Digoxin (Lanoxin®), a Sensitive P-glycoprotein (P-gp) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
Lexicon Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
A Phase 1, Single-center, Open-label, 2-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Rosuvastatin (Crestor®), a Sensitive Breast Cancer Resistance Protein (BCRP) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated:  7/8/2015
558
mi
from
Evansville, IN
DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin
A Phase 1, Single-center, Open-label, 2-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Rosuvastatin (Crestor®), a Sensitive Breast Cancer Resistance Protein (BCRP) Substrate, in Healthy Male and Female Subjects
Status: Enrolling
Updated: 7/8/2015
Lexicon Investigational Site
558
mi
from
Evansville, IN
Click here to add this to my saved trials
Measurement of Pulse Wave Velocity
Photoplethysmogram Measurement of Pulse Wave Velocity
Status: Enrolling
Updated:  7/9/2015
515
mi
from
Rochester, MN
Measurement of Pulse Wave Velocity
Photoplethysmogram Measurement of Pulse Wave Velocity
Status: Enrolling
Updated: 7/9/2015
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase 1 Study Comparing AVP-786 With AVP-923
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923
Status: Enrolling
Updated:  7/10/2015
344
mi
from
Dallas, TX
A Phase 1 Study Comparing AVP-786 With AVP-923
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923
Status: Enrolling
Updated: 7/10/2015
Covance Dallas Clinical Research Unit
344
mi
from
Dallas, TX
Click here to add this to my saved trials
Role of Flavanols In Cardiovascular Function in Healthy Aging
Effects of Dietary Flavanols on Cutaneous, Peripheral, and Cerebral Vascular Function in Young and Old Humans
Status: Enrolling
Updated:  7/13/2015
517
mi
from
Austin, TX
Role of Flavanols In Cardiovascular Function in Healthy Aging
Effects of Dietary Flavanols on Cutaneous, Peripheral, and Cerebral Vascular Function in Young and Old Humans
Status: Enrolling
Updated: 7/13/2015
University of Texas at Austin: Environmental and Autonomic Physiolgy Laboratory
517
mi
from
Austin, TX
Click here to add this to my saved trials
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults
Status: Enrolling
Updated:  7/14/2015
1148
mi
from
Baltimore, MD
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults
Status: Enrolling
Updated: 7/14/2015
National Institute of Aging
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Status: Enrolling
Updated:  7/15/2015
1329
mi
from
Stanford, CA
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being
Status: Enrolling
Updated: 7/15/2015
Stanford University, Department of Psychiatry and Behavioral Sciences
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1143
mi
from
San Diego, CA
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
408
mi
from
Englewood, CO
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
AboutSkin Dermatology and DermSurgery, PC
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1319
mi
from
Coral Gables, FL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Dermatology Research Institute
1319
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1320
mi
from
Coral Gables, FL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Stephan Baker, MD PA
1320
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1319
mi
from
Miami, FL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Baumann Cosmetic and Research Center
1319
mi
from
Miami, FL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1284
mi
from
West Palm Beach, FL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Kenneth R. Beer, MD, PA
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
599
mi
from
Arlington Hts, IL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Altman Dermatology Associates
599
mi
from
Arlington Hts, IL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
611
mi
from
Chicago, IL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
DeNova Research
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
582
mi
from
Naperville, IL
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
DuPage Medical Group, Dermatology Institute
582
mi
from
Naperville, IL
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1138
mi
from
Glendale, MD
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Callender Center for Clinical Research
1138
mi
from
Glendale, MD
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1120
mi
from
Rockville, MD
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Aesthetics, Skin Care, Dermatologic Surgery
1120
mi
from
Rockville, MD
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
617
mi
from
Nashville, TN
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Tennessee Clinical Research Center
617
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
330
mi
from
Plano, TX
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Research Across America
330
mi
from
Plano, TX
Click here to add this to my saved trials
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated:  7/15/2015
1385
mi
from
Vancouver,
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 7/15/2015
Shannon Humphrey, MD
1385
mi
from
Vancouver,
Click here to add this to my saved trials
Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans
Genetic Susceptibility TO Ozone-induced Bronchial Airway Inflammatory Responses In Humans
Status: Enrolling
Updated:  7/16/2015
1045
mi
from
Chapel Hill, NC
Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans
Genetic Susceptibility TO Ozone-induced Bronchial Airway Inflammatory Responses In Humans
Status: Enrolling
Updated: 7/16/2015
US EPA Human Studies Facility
1045
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated:  7/18/2015
1149
mi
from
San Juan Capistrano, CA
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
Capistrano Surgery Center
1149
mi
from
San Juan Capistrano, CA
Click here to add this to my saved trials
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated:  7/18/2015
1158
mi
from
Newport Beach, CA
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
Bleeding Volume Test: A Double-Blind Crossover Randomized Clinical Trial of an In-Vivo On-Line Test for Aspirin Effect and Resistance
Status: Enrolling
Updated: 7/18/2015
Private practice office
1158
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Immune Memory After Papillomavirus Vaccination
Immune Memory After Papillomavirus Vaccination (IMAP-I) Study . DMID 10-0014
Status: Enrolling
Updated:  7/20/2015
801
mi
from
Atlanta, GA
Immune Memory After Papillomavirus Vaccination
Immune Memory After Papillomavirus Vaccination (IMAP-I) Study . DMID 10-0014
Status: Enrolling
Updated: 7/20/2015
Emory University
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
A Double-Blind Randomized Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple 1200 mg Dose Intravenous Oritavancin Infusions in Healthy Subjects
Status: Enrolling
Updated:  7/20/2015
639
mi
from
West Bend, WI
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
A Double-Blind Randomized Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple 1200 mg Dose Intravenous Oritavancin Infusions in Healthy Subjects
Status: Enrolling
Updated: 7/20/2015
Clinical Research Facility
639
mi
from
West Bend, WI
Click here to add this to my saved trials
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers
Status: Enrolling
Updated:  7/20/2015
1309
mi
from
Miami Lakes, FL
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers
Status: Enrolling
Updated: 7/20/2015
Panax Clinical Research
1309
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Fermentation Rate of Infant Formula
Status: Enrolling
Updated:  7/21/2015
262
mi
from
Omaha, NE
Fermentation Rate of Infant Formula
Status: Enrolling
Updated: 7/21/2015
Boys Town National Research Hospital
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Status: Enrolling
Updated:  7/21/2015
521
mi
from
Austin, TX
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
Status: Enrolling
Updated: 7/21/2015
PPD Development, LP
521
mi
from
Austin, TX
Click here to add this to my saved trials
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated:  7/22/2015
1344
mi
from
New Haven, CT
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
CRU New Haven
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated:  7/22/2015
1344
mi
from
New Haven, CT
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects
Status: Enrolling
Updated: 7/22/2015
Pfizer New Haven Clinical Research Unit
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Status: Enrolling
Updated:  7/22/2015
552
mi
from
Minneapolis, MN
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Training Effects on Skeletal Muscle Fatty Acid Metabolism
Status: Enrolling
Updated: 7/22/2015
Univ of Minnesota
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Status: Enrolling
Updated:  7/28/2015
777
mi
from
Salt Lake City, UT
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
In Vivo Assessment of Silver Biomaterial Nano-Toxicity
Status: Enrolling
Updated: 7/28/2015
University of Utah Hospital and Clinics
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
A Phase 1, Randomized, Open-label, Parallel-group Study To Evaluate The Pharmacokinetics Of Pf-04856883 (Cvx-096) Following Subcutaneous Administration In Healthy Volunteers
Status: Enrolling
Updated:  7/30/2015
1344
mi
from
New Haven, CT
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
A Phase 1, Randomized, Open-label, Parallel-group Study To Evaluate The Pharmacokinetics Of Pf-04856883 (Cvx-096) Following Subcutaneous Administration In Healthy Volunteers
Status: Enrolling
Updated: 7/30/2015
New Haven Clinical Research Unit
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated:  7/30/2015
1154
mi
from
Orange, CA
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Status: Enrolling
Updated: 7/30/2015
Chao Family Comprehensive Cancer Center
1154
mi
from
Orange, CA
Click here to add this to my saved trials
Linking National Guard Veterans With Need to Mental Health Care
Linking National Guard Veterans With Need to Mental Health Care
Status: Enrolling
Updated:  7/31/2015
801
mi
from
Ann Arbor, MI
Linking National Guard Veterans With Need to Mental Health Care
Linking National Guard Veterans With Need to Mental Health Care
Status: Enrolling
Updated: 7/31/2015
VA Ann Arbor Healthcare System
801
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1158
mi
from
Newport Beach, CA
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1158
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1339
mi
from
San Francisco, CA
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1174
mi
from
West Hollywood, CA
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1174
mi
from
West Hollywood, CA
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1299
mi
from
Boca Raton, FL
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1299
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1319
mi
from
Coral Gables, FL
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1319
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1138
mi
from
Glenn Dale, MD
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
1138
mi
from
Glenn Dale, MD
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
1438
mi
from
Chestnut Hills, MA
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
1438
mi
from
Chestnut Hills, MA
Click here to add this to my saved trials
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated:  7/31/2015
418
mi
from
St Louis, MO
Safety Study of ATX-101 in Subjects With Varying Chin Sizes
A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4
Status: Enrolling
Updated: 7/31/2015
Clinical Research Facility
418
mi
from
St Louis, MO
Click here to add this to my saved trials
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Status: Enrolling
Updated:  7/31/2015
851
mi
from
Phoenix, AZ
Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Status: Enrolling
Updated: 7/31/2015
Pulmonary Associates, 1112 E. McDowell Rd.
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Status: Enrolling
Updated:  8/3/2015
1329
mi
from
Palo Alto, CA
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly
Status: Enrolling
Updated: 8/3/2015
VA Palo Alto HCS
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Circadian Brown Adipose Tissue Metabolism
A Pilot Study to Investigate Circadian Variations in Brown Adipose Tissue Metabolism in Healthy Volunteers.
Status: Enrolling
Updated:  8/3/2015
1223
mi
from
Philadelphia, PA
Circadian Brown Adipose Tissue Metabolism
A Pilot Study to Investigate Circadian Variations in Brown Adipose Tissue Metabolism in Healthy Volunteers.
Status: Enrolling
Updated: 8/3/2015
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
A Randomized, Placebo-Controlled, Four-Period Crossover Definitive QT Study Of The Effects of APF530 Exposure, High-Dose IV Granisetron and Moxifloxacin on QTc Prolongation
Status: Enrolling
Updated:  8/3/2015
638
mi
from
West Bend, WI
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
A Randomized, Placebo-Controlled, Four-Period Crossover Definitive QT Study Of The Effects of APF530 Exposure, High-Dose IV Granisetron and Moxifloxacin on QTc Prolongation
Status: Enrolling
Updated: 8/3/2015
Spaulding Clinical Research, LLC
638
mi
from
West Bend, WI
Click here to add this to my saved trials